Page 14 - Read Online

Page 116 Aziz et al. Cancer Drug Resist 2020;3:113-6 I http://dx.doi.org/10.20517/cdr.2020.06

11. Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med 2020;12:8.
12. Goutsouliak K, Veeraraghavan J, Sethunath V, Angelis CD, Osborne CK, et al. Towards personalized treatment for early stage HER2-
positive breast cancer. Nat Rev Clin Oncol 2019; Epub ahead of print. doi:10.1038/s41571-019-0299-9.
13. Ponnusamy L, Mahalingaiah PKS, Chang YW, Singh KP. Role of cellular reprogramming and epigenetic dysregulation in acquired
chemoresistance in breast cancer. Cancer Drug Resist 2019;2:297-312.
14. Seno A, Mizutani A, Aizawa K, Onoue R, Masuda J, et al. Daunorubicin can eliminate iPS-derived cancer stem cells via ICAD/CAD-
independent DNA fragmentation. Cancer Drug Resist 2019;2:335-50.
15. Janczar S, Janczar K, Pastorczak A, Harb H, Paige AJW, et al. The role of histone protein modifications and mutations in histone
modifiers in pediatric B-cell progenitor acute lymphoblastic leukemia. Cancers (Basel) 2017;9.
16. Meyer LK, Hermiston ML. The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.
Cancer Drug Resist 2019;2:313-25.
17. Jia ZH, Wang XG, Zhang H. Overcome cancer drug resistance by targeting epigenetic modifications of centrosome. Cancer Drug
Resist 2019;2:210-24.
18. Galon J, Bruni D. Tumor immunology and tumor evolution: intertwined histories. Immunity 2020;52:55-81.
19. Peixoto P, Renaude E, Boyer-Guittaut M, Hervouet E. Epigenetics, a key player of immunotherapy resistance. Cancer Drug Resist
2018;1:219-29.
20. Morales S, Monzo M, Navarro A. Epigenetic regulation mechanisms of microRNA expression. Biomol Concepts 2017;8:203-12.
21. Ahmad A, Li Y, Bao B, Kong D, Sarkar FH. Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Mol Nutr
Food Res 2014;58:79-86.
22. Ediriweera MK, Cho SK. Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies
for breast cancer. Pharmacol Ther 2019;206:107437.
23. Biersack B. Alkylating anticancer agents and their relations to microRNAs. Cancer Drug Resist 2019;2:1-17.